Obinutuzumab as Initial or Second-Line Therapy in Patients With Primary Membranous Nephropathy
2024 · Kidney International Reports · 27 citations
https://doi.org/10.1016/j.ekir.2024.05.004
X
Xiaole Su
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
40
Papers
834
Citations
15
h-index
18
i10-index
Xiaole Su is an academic researcher from Shanxi Medical University. The author has contributed to research in topics: Renal Diseases and Glomerulopathies & Acute Kidney Injury Research & Chronic Kidney Disease and Diabetes. The author has an h-index of 15, co-authored 34 publications.
ORCID: 0009-0002-3781-8773Papers by this author
worksIntermedin attenuates renal fibrosis by induction of heme oxygenase-1 in rats with unilateral ureteral obstruction
2017 · BMC Nephrology · 18 citations
https://doi.org/10.1186/s12882-017-0659-6
Papulonodular mucinosis, Guillain-Barré syndrome and nephrotic syndrome in a patient with systemic lupus erythematosus: a case report
2017 · BMC Nephrology · 13 citations
https://doi.org/10.1186/s12882-017-0458-0
Effects of oral alkali drug therapy on clinical outcomes in pre-dialysis chronic kidney disease patients: a systematic review and meta-analysis
2022 · Figshare · 1 citations
https://doi.org/10.6084/m9.figshare.19195019.v1
Cardiovascular and kidney outcomes of uric acid-lowering therapy in patients with different kidney functions: study protocol for a systematic review, pairwise and network meta-analysis
2023 · BMJ Open · 1 citations
https://doi.org/10.1136/bmjopen-2021-059096
Response to the Letter to the Editor Entitled “Reconsideration of Response Assessment in Obinutuzumab-Treated Membranous Nephropathy”
2026 · Kidney International Reports · 1 citations
https://doi.org/10.1016/j.ekir.2026.103775
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat